Ambulatory Blood Pressure Monitoring (ABPM) Devices Market Research Report 2017-2023
Ambulatory Blood Pressure Monitoring (ABPM) Devices Market by Product (Arm and Wrist ABPM Devices) and End User (Hospitals, Ambulatory Surgical Centers, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023
- Report Number: 1615
- Publish Date: 19-May-2018
- Pages: 175
- Tables: 90
Ambulatory Blood Pressure Monitoring (ABPM) Devices Market Overview:
The Global Ambulatory Blood Pressure Monitoring (ABPM) Devices Market was valued at $78 million in 2016, and is projected to reach $128 million at a CAGR of 7.2% from 2017 to 2023. ABPM devices are medical devices used to measure blood pressure at regular intervals, even while the patient is asleep. ABPM patient monitors are non-invasive instruments used for measuring blood pressure and it can be carried over patient for 24 hours in their own environment. ABPM monitors read the pulse rate to calculate the blood pressure and can be worn either at arms or wrist.
The market is driven majorly due to rise in number of hypertension cases, owing to increasing prevalence of diabetes, obesity, and cardiovascular diseases. Moreover, growth in geriatric population, increase in demand for non-invasive method of measuring blood pressure, and transformation from physician-centered to the patient-centered model has resulted in increase of patients availing this treatment option. However, the market growth is limited by high cost of ABPM devices and lack of awareness about ambulatory blood pressure in emerging countries. Conversely, rise in healthcare infrastructure and increase in healthcare expenditure in emerging countries are expected to provide lucrative opportunities for the market expansion during the forecast period.
Ambulatory Blood Pressure Monitoring (ABPM) Devices Market Segmentation
The global ABPM devices market is segmented based on product, end user, and region. Based on product, the market is bifurcated into arm ABPM devices and wrist ABPM devices. Depending on end user, it is categorized into hospitals, ambulatory surgical centers (ASCs), and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Arm ABPM devices segment accounted for the largest market share in 2016 and is expected to remain so throughout the forecast period. It is small digital blood pressure measuring device that is attached to a belt around the patients body and it is connected to a cuff, wrapped around upper arm. It is small enough that it can be carried anywhere during normal daily life and can be used even during sleep. Factors such as high availability of arm ABPM monitors, accuracy of these devices, and high adoption of these devices drive the market growth for arm ABPM monitors. In addition, growth in healthcare expenditure, rise in awareness about ABPM, and availability of newer and advanced arm ABPM devices further boost the market growth in near future.
Based on region, the global market is segmented into North America, Europe, Asia-Pacific, and LAMEA. North America held the largest share of the market in 2016, followed by Europe. On the other hand, Asia is anticipated to be the fastest-growing regional segment during the analysis period. The key factors that drive the growth of this market include increase in pool of patient population, rise in prevalence of different types of diseases such as diabetes and cardiovascular diseases, and high adoption of non-invasive methods for measuring blood pressure. Asia-Pacific is expected to emerge as the area with maximum growth potential due to focus of key players in the emerging economies and improving healthcare infrastructure.
Snapshot of LAMEA ABPM Devices Market
Rise in focus of market vendors on emerging markets, namely, Asia-Pacific and LAMEA regions, is expected to boost the market growth. According to a study in June 2017, by Wits University scientists has revealed that South Africa has the highest prevalence of hypertension in southern Africa. Moreover, they estimated that there is15% prevalence of hypertension in the west of southern Africa and 25% in the east of southern Africa. Hence, people in these areas are prone to encounter hypertension during their lifetime. Thus, LAMEA offers a huge customer base to the manufacturers of ABPM devices market.
The key players of this market include Spacelabs Healthcare, Inc., Welch Allyn, Inc., SunTech Medical, Schiller AG, Bosch & Sohn GmbH & Co. KG, Contec Inc. (Parent Company: DAIFUKU CO., LTD.), GE Company, Rudolf Riester GmbH, Vaso Corporation, and BPL Group.
Other players involve Mortara Instrument, Inc., Daray Medical, Omron Healthcare Company, and Microlife Corporation.
- The study provides an in-depth analysis of the global ambulatory blood pressure monitoring (ABPM) devices market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Ambulatory Blood Pressure Monitoring (ABPM) Devices Market Key Segments:
- Arm ABPM Devices
- Wrist ABPM Devices
By End User
- Ambulatory Surgical Centers (ASCs)
- Other End Users
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA
Table Of Content
Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.4.1. Secondary research
Chapter: 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2.1. Top investment pockets
3.3. TOP PLAYER POSITIONING
184.108.40.206. Growing prevalence of hypertension condition
220.127.116.11. High cost of ABPM devices
18.104.22.168. Increase in healthcare expenditure in emerging economies
3.5. PATENT ANALYSIS
3.5.1. Patent analysis, by year
Chapter: 4 AMBULATORY BLOOD PRESSURE MONITORING DEVICES MARKET, BY PRODUCT
4.1.1. Market size and forecast
4.2. ARM ABPM DEVICES
4.2.1. Key market trends, growth factors, and opportunities
4.3. WRIST ABPM DEVICES
4.3.1. Key market trends, growth factors, and opportunities
Chapter: 5 AMBULATORY BLOOD PRESSURE MONITORING DEVICES MARKET, BY END USER
5.1.1. Market size and forecast
5.2.1. Market size and forecast, by region
5.3. AMBULATORY SURGICAL CENTERS (ASCS)
5.3.1. Market size and forecast, by region
5.4. OTHER END USERS
5.4.1. Market size and forecast, by region
Chapter: 6 AMBULATORY BLOOD PRESSURE MONITORING DEVICES MARKET, BY REGION
6.1. Market size and forecast
6.2.1. Key market trends, growth factors, and opportunities
22.214.171.124.1. U.S. ABPM devices market, by product
126.96.36.199.1. Canada ABPM devices market, by product
188.8.131.52.1. Mexico ABPM devices market, by product
6.2.3. North America ABPM devices market, by product
6.3.1. Key market trends, growth factors, and opportunities
184.108.40.206.1. Germany ABPM devices market, by product
220.127.116.11.1. France ABPM devices market, by product
18.104.22.168.1. UK ABPM devices market, by product
22.214.171.124.1. Italy ABPM devices market, by product
126.96.36.199.1. Spain ABPM devices market, by product
188.8.131.52. Rest of Europe
184.108.40.206.1. Rest of Europe ABPM devices market, by product
6.3.3. Europe ABPM devices market, by product
6.4.1. Key market trends, growth factors, and opportunities
220.127.116.11.1. Japan ABPM devices market, by product
18.104.22.168.1. China ABPM devices market, by product
22.214.171.124.1. Australia ABPM devices market, by product
126.96.36.199.1. India ABPM devices market, by product
188.8.131.52. South Korea
184.108.40.206.1. South Korea ABPM devices market, by product
220.127.116.11. Rest of Asia-Pacific
18.104.22.168.1. Rest of Asia-Pacific ABPM devices market, by product
6.4.3. Asia-Pacific ABPM devices market, by product
6.5.1. Key market trends, growth factors, and opportunities
22.214.171.124.1. Brazil ABPM devices market, by product
126.96.36.199. Saudi Arabia
188.8.131.52.1. Saudi Arabia ABPM devices market, by product
184.108.40.206. South Africa
220.127.116.11.1. South Africa ABPM devices market, by product
18.104.22.168. Rest of LAMEA
22.214.171.124.1. Rest of LAMEA ABPM devices market, by product
6.5.3. LAMEA ABPM devices market, by product
Chapter: 7 COMPANY PROFILE
7.1. BOSCH & SOHN GMBH & CO. KG
7.1.1. Company overview
7.2. BPL LTD.
7.2.1. Company overview
7.3. CONTEC MEDICAL SYSTEMS CO. LTD.
7.3.1. Company overview
7.4. GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)
7.4.1. Company overview
7.5. HALMA PLC.
7.5.1. Company overview
7.6. HILL ROM HOLDINGS, INC. (WELCH ALLYN HOLDINGS, INC.)
7.6.1. Company overview
7.7. OMRON CORPORATION
7.7.1. Company overview
7.8. OSI SYSTEMS, INC. (SPACELABS HEALTHCARE, INC.)
7.8.1. Company overview
7.9. SCHILLER AG
7.9.1. Company overview
7.10. VASO CORPORATION
7.10.1. Company overview
LIST OF TABLES
TABLE 1. PATENTS REGISTERED/APPROVED IN THE WORLD, 2011-2017
LIST OF FIGURES
FIGURE 1. AMBULATORY BLOOD PRESSURE MONITORING DEVICES MARKET SEGMENTATION
The adoption of ambulatory blood pressure monitoring devices is expected to gain growth due to rise in number of hypertension cases due to increase in cardiovascular diseases, diabetes, and obesity. This device measures the blood pressure throughout the day and even during sleep, offering 24-hour continuous blood pressure readings.
Upsurge in cases of cardiovascular diseases and increase in prevalence of diabetes leads to high blood pressure, thus making it imperative to use these monitors for the measurement of ABPM. Moreover, factors such as growth in demand for non-invasive methods for monitoring blood pressure, rise in geriatric population, and a shift from physician centered model to personalized model are projected to supplement the market growth. However, high cost of ABPM devices and lack of awareness about ABPM monitoring are expected to impede the market growth.
The use of ABPM patient monitors is the highest in North America, attributable to increased awareness about the white coat hypertension condition and heavy expenditure by the government on healthcare, followed by Europe and Asia-Pacific. In addition, ABPM patient monitor providers and distributors have focused on expanding their presence in the emerging economies, which is anticipated to drive the market growth.